Internal Medicine, Endocrinology, Diabetes, & Metabolism · Moline, IL
NPI
1548541154
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
612 35th Ave, Ste 1
Moline, IL, 61265
Phone (309) 788-0014
Groups this clinician bills Medicare through
Medicare paid, 2024
$154K
6,549 services
Medicare patients, 2024
444
Average age 73
Drug cost, 2024
$3.0M
6,040 prescriptions
Company payments, 2025
$65.28
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramarao Pradeep was code J0897 (injection, denosumab, 1 mg), 1,680 times for 21 patients. In total Ramarao Pradeep billed 6,549 services in 18 codes, and Medicare paid $154K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,680 | 21 | $20.42 | $34K |
| 99214 Office E&M - Established | Office | 764 | 355 | $84.14 | $64K |
| 95251 Test - Miscellaneous | Office | 263 | 118 | $24.26 | $6,381 |
| 99213 Office E&M - Established | Office | 192 | 147 | $50.89 | $9,770 |
| 96372 Injection Administration | Office | 58 | 26 | $10.24 | $594 |
| 83036 Blood Count | Office | 42 | 40 | $9.52 | $400 |
| 99204 Office E&M - New | Office | 23 | 23 | $96.58 | $2,221 |
| 99203 Office E&M - New | Office | 18 | 18 | $65.61 | $1,181 |
| 99215 Office E&M - Established | Office | 14 | 13 | $60.99 | $854 |
By year: 2022 $179K for 5,931 services; 2023 $225K for 10,307 services; 2024 $154K for 6,549 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 42 | 40 | $9.52 | $400 |
Medicare prescription drug claims, 2024
In 2024, the drug Ramarao Pradeep prescribed most often to Medicare patients was Levothyroxine Sodium, with 644 prescriptions and refills. In total Ramarao Pradeep wrote 6,040 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 644 | 1,782 | 193 | $6,860 |
| Atorvastatin Calcium Generic | 527 | 1,464 | 164 | $5,537 |
| Metformin Hcl Generic | 403 | 1,111 | 127 | $3,139 |
| Ozempic Semaglutide | 396 | 775 | 108 | $746K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 300 | 767 | 104 | $54K |
| Jardiance Empagliflozin | 243 | 573 | 69 | $332K |
| Mounjaro Tirzepatide | 211 | 307 | 45 | $325K |
| Tresiba Flextouch U-100 Insulin Degludec | 187 | 485 | 65 | $188K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 185 | 489 | 81 | $27K |
| Humalog Kwikpen U-100 Insulin Lispro | 162 | 374 | 58 | $51K |
| Novolog Flexpen Insulin Aspart | 129 | 256 | 48 | $31K |
| Metformin Hcl Er Metformin Hcl | 124 | 339 | 38 | $1,465 |
| Ezetimibe Generic | 116 | 328 | 40 | $2,970 |
| Glipizide Generic | 115 | 314 | 35 | $1,369 |
| Glimepiride Generic | 113 | 308 | 40 | $1,450 |
Brand drugs: 2,993 claims; generic drugs: 2,577 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramarao Pradeep $65.28 ($65.28 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $65.28.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 3 | $65.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.